Related Experiment Video
Updated: Aug 3, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Control of p53 ubiquitination and nuclear export by MDM2 and ARF
1Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Abstract:
p53 and ARF-INK4a are the two most frequently altered loci in human tumors. The activity of p53 protein is inhibited during normal cell growth by the proto-oncoprotein MDM2 through either repression of p53-mediated transcription in the nucleus or proteasomal degradation of p53 protein in the cytoplasm. Responding to oncogenic signal-activated cell hyperproliferation, ARF-mediated antagonism of MDM2 inhibition results in p53 becoming active and its protein levels rising. The biochemical mechanisms of ubiquitination and nuclear export that underlie the functions of ARF and MDM2 in p53 control continue to emerge.
Insights
The tumor suppressor p53 is regulated by MDM2 and ARF. ARF antagonizes MDM2, activating p53 during cell hyperproliferation, a key process in cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- p53 and ARF-INK4a are frequently altered in human tumors.
- MDM2 proto-oncoprotein inhibits p53 activity via transcriptional repression or proteasomal degradation.
- Dysregulation of these pathways is critical in cancer progression.
Purpose of the Study:
- To elucidate the regulatory mechanisms of p53 activity by MDM2 and ARF.
- To understand the biochemical basis of ARF and MDM2 interactions in p53 control.
- To explore the roles of ubiquitination and nuclear export in this pathway.
Main Methods:
- Investigating protein-protein interactions between p53, MDM2, and ARF.
- Utilizing biochemical assays to study ubiquitination and degradation pathways.
- Employing cell-based assays to monitor p53 activity and localization.
- Analyzing nuclear export mechanisms.
Main Results:
- MDM2 directly inhibits p53 through nuclear and cytoplasmic mechanisms.
- ARF antagonizes MDM2's inhibitory function, leading to p53 activation.
- Emerging evidence points to ubiquitination and nuclear export as key regulatory steps.
Conclusions:
- The interplay between p53, MDM2, and ARF is crucial for tumor suppression.
- Understanding the biochemical details of ARF and MDM2 in p53 regulation offers therapeutic targets.
- Further research into ubiquitination and nuclear export will refine our knowledge of cancer biology.
Related Concept Videos
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
DNA Damage can Stall the Cell Cycle
Regulation of Nuclear Protein Sorting
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle

